Direct Access Carotid Artery Stenting Using the Neuroguard IEP System (PERFORMANCE III)

Completed · Not applicable

Conditions studied: Carotid Stenosis, Carotid Artery Diseases

In brief

The PERFORMANCE III study is a prospective, multicenter single-arm, open label study to evaluate the safety and effectiveness of the Neuroguard IEP® Direct System for the treatment of carotid artery stenosis in subjects at elevated risk for carotid endarterectomy (CEA). Eligible patients greater than or equal to 20 years of age and less than or equal to 82 years of age, are those who have been diagnosed with either de-novo atherosclerotic or post CEA restenotic lesion(s) in the internal carotid arteries (ICA) or at the carotid bifurcation with greater than or equal to 50% stenosis if symptomatic or greater than or equal to 70% stenosis if asymptomatic.

Key facts

Study ID
NCT05845710
Run by
Contego Medical, Inc.
People needed
178
Starts
2023-10-05
Expected to finish
2025-08-12
Last updated by the study team
2026-03-06

Who can join

Age: 20 and older, up to 82. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.